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Edited by Hans-Dieter KlenkAbstract Despite the high homology between human immuno-
deﬁciency virus type-1 (HIV-1) and human immunodeﬁciency
virus type-2 (HIV-2) reverse transcriptases (RTs), the ribonucle-
ase H (RNase H) level of HIV-2 RT is lower than that of HIV-1
RT, while the DNA polymerase of both RTs is similar. We con-
ducted mutagenesis of HIV-2 RT Gln294 (shown to control the
RNase H activity level when modiﬁed to a Pro in the smaller
p54 subunit and not in the larger p68 subunit) to various residues,
and assayed the activities of all mutants. All exhibited an RNase
H that is higher than the wild-type (WT) HIV-2 RT level,
although the DNA polymerase of all mutants equals WT HIV-2
RT level. These results represent a unique case, where every
mutation induces an increase rather than a decrease in an en-
zymes activity.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Reverse transcriptases (RTs) of retroviruses have two enzy-
matic activities, a DNA polymerase (that copies both RNA
and DNA templates) and the ribonuclease H (RNase H) activ-
ity that hydrolyzes the RNA in DNA–RNA hybrids [1,2]. The
fundamental role in the replication of retroviruses makes RT a
major target for the drug treatment against human immunode-
ﬁciency virus type-1 (HIV-1) and human immunodeﬁciencyAbbreviations: RT, reverse transcriptase; HIV-1, human immunodeﬁ-
ciency virus type-1; HIV-2, human immunodeﬁciency virus type-2;
RNase H, ribonuclease H; AIDS, acquired immunodeﬁciency syn-
drome; WT, wild-type; IPTG, isopropyl b-thiogalactopyranoside
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doi:10.1016/j.febslet.2008.07.010virus type-2 (HIV-2), the lentiviruses that cause human ac-
quired immunodeﬁciency syndrome (AIDS). Both HIV RTs
are heterodimeric proteins, each composed of two polypep-
tides, the p66/p51 for HIV-1 RT or p68/p54 for HIV-2 RT
[3–7]. The larger subunit in both RTs is composed of two do-
mains, DNA polymerase and RNase H. The polymerase do-
main, located in the amino terminal portion, resembles a
right hand with ﬁngers, palm and thumb subdomains. It is
joined to the RNase H domain, located at the carboxyl termi-
nus of the larger subunit, by a connection subdomain [3,5–7].
The DNA polymerase active site is located within the palm
subdomain of the p66 or p68 subunit of either HIV-1 or
HIV-2 RT, respectively. The smaller RT subunit is a cleavage
product of the larger one (where the entire carboxyl terminal
segment is removed); hence, the smaller subunit lacks the
RNase H domain. Even though the amino acid sequence of
this subunit is identical to the larger subunit, the ﬁngers, palm
and thumb fold diﬀerently in the heterodimeric protein. Other
polymerases also show an overall resemblance to a right hand
structure with the active site located within the palm subdo-
main. These include the DNA-dependent DNA polymerases
of both polymerase b and the Klenow large fragment of Esch-
erichia coli polymerase I [8,9], the DNA-dependent RNA poly-
merase of T7, the RNA-dependent RNA polymerase of
poliovirus [10,11] and the RT of murine leukemia retrovirus
[12,13].
The speciﬁc DNA polymerase activities of puriﬁed recombi-
nant RTs of HIV-1 and HIV-2 are similar. However, the spe-
ciﬁc RNase H activity of HIV-2 RT from both Rod and
D194 strains was shown in several studies to be up to about
ten-fold lower than that of HIV-1 RT [14–19]. Unexpectedly,
part of the polymerase domain, rather than the RNase H do-
main per se was found by us to have a signiﬁcant eﬀect on the
level of the RNase H activity [17,18]. The observed diﬀerence
in the RNase H activity between the HIV-1 and HIV-2 RTs is
quantitative rather than qualitative, as the pattern of RNA
cleavage by the two RTs is indistinguishable. We have found
that the thumb subdomain of the smaller RT subunit has a ma-
jor role in determining the level of the RNase H activity, either
through interactions with the RNase H catalytic domain of the
larger subunit or with the substrate molecules themselves [17].
Interestingly, previous observations have shown that the iso-
lated thumb subdomain of HIV-1 RT has only a marginal stim-
ulatory eﬀect on the RNase H activity of the RT [20]. Later on,
a single residue, Gln294, located in the thumb of the small
HIV-2 RT subunit, was shown to be solely responsible for theblished by Elsevier B.V. All rights reserved.
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HIV-2 RT, where Gln294 was replaced by a proline (that is
the comparable residue located at this position in HIV-1 RT),
has an activity as high as that of HIV-1 RT [16]. Moreover, it
was shown that while the Gln294 in the small RT subunit has
a major impact on the RNase H activity, the identical residue
on the larger RT subunit has hardly any eﬀect. Steady state
kinetics revealed that residue 294 in the small RT subunit aﬀects
the Km rather than the kcat value; thus inﬂuencing the aﬃnity of
the enzyme towards the RNA–DNA substrate. As could be ex-
pected, we also found that the reciprocal mutation P294Q
mutation of HIV-1 RT leads to a substantial reduction in the
enzymes speciﬁc RNase H activity [16].
In the present investigation we have addressed the question
as to how various amino acids, other that Gln and Pro at posi-
tion 294 of HIV-2 RT aﬀect the enzymes RNase H activity.
This was done by a systematic mutagenesis of Gln294 to 10
diﬀerent residues (in addition to the Pro mutant already stud-
ied) that represent all diﬀerent chemical types of amino acid
side chains. The results show that all modiﬁcations of HIV-2
RT Gln294 lead to an increase of the RNase H activity of
the enzyme relative to the wild-type (WT) HIV-2 RT and also
support our previous observations that residue 294 in the p54
subunit of the RT is the major contributor to the level of this
activity in HIV-2 RT. These results indicate an exceptional
case where every mutation of a particular residue brings about
an increase rather than a decrease in the speciﬁc catalytic activ-
ity of the studied enzyme.2. Materials and methods
2.1. Plasmid construction for the expression of RTs
All recombinant versions of both HIV-1 and HIV-2 RT used in this
study were expressed in E. coli with six-histidine tags [16]. The plas-
mids, designated pHIV-1 RT and pHIV-2 RT, induce the expression
of the WT heterodimeric RTs of the HIV-1 BH-10 isolate and the
HIV-2 Rod isolate [14,21]. In these plasmids, the genes that encode
the large subunit of the RT (p66 or p68 for HIV-1 RT or HIV-2
RT, respectively) were introduced in the pT5m plasmid along with
the genes encoding the relevant HIV-1 or HIV-2 protease [17]. The
co-expression of the RT and protease proteins was induced by isopro-
pyl b-thiogalactopyranoside (IPTG) in the BL21(DE3)pLysS E. coli
strain, leading to the simultaneous expression of both the large RT
subunit and the protease. This causes the homodimeric RT to be pro-
teolytically cleaved in the bacteria, leading to the accumulation of the
heterodimeric p66/p51 and p68/p54 for HIV-1 RT or HIV-2 RT,
respectively.
In order to generate the new Gln294 mutants of HIV-2 RT used in
this study, we have employed a cassette mutagenesis method described
for the mutagenesis of HIV-1 RT and HIV-2 RT [4,16]. We have con-
structed a BspMI cassette by introducing the BspMI restriction site
into the HIV-2 RT coding region in the pUC12N HIV-2 RT expressing
plasmid (in which the HindIII site downstream to the RT-coding insert
was replaced by a NotI restriction site). The cassette diﬀers from the
parental HIV-2 RT expressing plasmid in that 100 bp of the RT se-
quence were deleted. This deleted segment, which codes for the resi-
dues from glycine 285 to tyrosine 318 in the HIV-2 RT protein, was
replaced by DNA segment containing a HindIII recognition site
ﬂanked by two BspMI sites, orientated at opposite directions. The syn-
thetic DNA fragments inserted in the BspMI cassette contained the RT
coding segments with the speciﬁc mutations. The phosphorylated olig-
omers were ligated into the linearized BspMI cassette – containing
plasmid. After transforming E. coli DH5a, the DNA of the selected
plasmids was sequenced for veriﬁcation. The mutant RTs-expressing
genes were used to replaced the gene for the WT HIV-2 RT in the vec-
tor HIV-2 RT (Rod) [16]; thus generating the vectors for expressing the
heterodimeric mutant HIV-2 RT versions with identical modiﬁcationsin both subunits. The subunit-selective mutant of HIV-2 RT was also
expressed from the plasmid constructed to co-express separately the
two HIV-2 RT subunits [16,17], the large one as a WT protein and
the small subunit as the Q294R mutant.
2.2. Protein puriﬁcations
All recombinant six-histidines-tagged RT versions were puriﬁed as
described in detail previously [17]. Brieﬂy, the bacterial extracts under-
went ﬁrst an aﬃnity chromatography using Ni-Agarose to enrich for
the histidines-tagged proteins and the RT-containing fractions were
further puriﬁed by carboxyl-methyl Sepharose ion exchange chroma-
tography. All RT versions were highly pure as judged from polyacryl-
amide gel analysis and were devoid of any detectable non-speciﬁc
nuclease activities (data not shown).
2.3. RNase H assay
This assay has been previously described in detail [16,17]. In brief, it
monitors the cleavage of [32P]5 0-end labeled 267 nt RNA, synthesized
in vitro from the pBLRA30 plasmid. This RNA, derived from the
U5 and R regions of HIV-1 genome, was annealed to a 20 nt-long syn-
thetic oligonucleotide DNA with the sequence 5 0-AGTTAGCCAGA-
GAGCTCCCA-3 0 (see scheme in Fig. 1A). The RNase H cleavage
products were electrophoretically resolved on a denaturating sequenc-
ing polyacrylamide gel, and the dried gels underwent autoradiography.
2.4. Strand-transfer assay
This assay was also described in detail previously [4,16,17]. A [32P]5 0-
end labeled 20nt synthetic DNA (5 0-CACACAACAGACGGGCA-
CAC-3 0) was annealed to the same 267 nt RNA used in the RNase
H assay (and serves in the strand-transfer assay as the primary RNA
template). A second 144 nt RNA (synthesized from the pG89 plasmid)
was used as the secondary or the acceptor RNA template. (See scheme
in Fig. 2A). The products of the combined DNA polymerase/RNase H
reactions (performed in the presence of RTs and all four dNTPs) were
resolved on denaturating polyacrylamide gels and the pattern of the 5 0-
end labeled DNA products was analyzed after autoradiography.
2.5. The DNA polymerase activity
This RT-associated activity was determined using poly(rA)noli-
go(dT)12-18 as the template-primer and [
3H]dTTP as the incorporated
deoxynucleotide triphosphate, as was described in detail previously
[15,16].3. Results
The research presented herein was designed to address the
question how various residues, other than Gln and Pro at po-
sition 294 of HIV-2 RT can aﬀect the RNase H activity of the
enzyme. This was done by a ‘‘vertical’’ mutagenesis of Gln294
to various residues that represent the diﬀerent amino acids
groups, and by observing the eﬀects of these mutations on
the activities of the various RT mutants generated. In these
HIV-2 RT mutants, Gln294 was modiﬁed in both the p68/
p54 subunits to either of the follow residues: Asn, Ser, Cys,
Ala, Glu, Arg, His, Met, Trp and Tyr. These residues were
chosen, since they represent the various amino acid groups,
as described in Table 1. Additionally, we have tested the
Q294P mutant, already studied by us previously, that repre-
sents the conversion of the Gln in WT HIV-2 RT to the Pro
of WT HIV-1 RT [16]. All recombinant RT versions were ex-
pressed in bacteria as heterodimeric p68/p54 RT isoforms and
the proteins underwent extensive puriﬁcations, yielding highly
puriﬁed enzymes (data not shown).
3.1. RNase H activity of all Gln294 mutants of HIV-2 RT
All highly puriﬁed heterodimeric RT versions were assayed
for their RNase H activities, using the method described in de-
Fig. 1. RNase H activity of the Gln294 HIV-2 RT mutants studied. (A) Schematic description of the enzymatic assay. The 267 nt RNA, synthesized
in vitro from the pBLRA30 plasmid, as was described in Section 2. This RNA was annealed to a synthetic 20 nt complementary oligomeric DNA.
The primary RNase H cleavages are near position 47, approximately 17 bases downstream of the 5 0 end of the RNA and the secondary cleavages are
near position 38 (8 nt upstream from the primary cleavage). The RNA and DNA substrates and the cleavages are shown schematically. The drawings
are not to scale. (B) 20 ng of each heterodimeric RT were incubated with the [32P]-end labeled RNase H substrate for 15 s or 1 min at 37 C (marked
as 1 and 2, respectively). The reaction products were resolved by urea-PAGE and the gel underwent autoradiography. The two controls RTs of this
assay, wild-type HIV-1and HIV-2 RTs (designated HIV-1 and HIV-2, respectively) were assayed along with the 11 HIV-2 RT mutants tested in this
study. Each RT mutant is designated by the single letter code of the substituting amino acid. The subunit mutated HIV-2 RT (with a wild-type p68
and a Q294R p54) is designated Q/R, and is shown next to the Q294R HIV-2 RT (in which both subunits possess the Arg294 mutation).
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Fig. 1A). Fig. 1B shows the pattern of the RNA cleavage in
the RNA–DNA hybrids by the various mutant HIV-2 RTs,
in comparison to the WT HIV-1 and HIV-2 RTs. We have al-
ready shown that the patterns generated by both WT HIV-1
and HIV-2 RTs, as well as by all previous chimeric and mutant
RTs tested, were similar [4,16,17]. Hence, it is not surprising
that the same is also true for all newly generated mutants of
HIV-2 RT. Since the ﬁrst cleavage generates a 47 nt long prod-
uct, the RNA is cut 17 nt away from the 3 0-end of the DNA
primer. Consequently, in thereby-employed polymerase-
dependent RNase H assay the molecular distance between
the DNA polymerase and the RNase H active sites of the
RT equals to about 17 nt. The secondary cleavage generates
38 nt-long RNA fragments (the 8 nt cleavage). The extent
of RNA cleavage was quantiﬁed and the initial velocity of
RNA cleavage (calculated after 15 s of incubation) is summa-
rized in Table 1. The presented values are the averages of three
independently-performed experiments. All mutations incorpo-
rated into the HIV-2 RTs have led to a surprising increase in
the RNase H speciﬁc activity rather than losing any activity.
Generally, all mutations induced the RNase H speciﬁc activity
to a level comparable to that typical to WT HIV-1 RT and the
related Q294P mutant HIV-2 RT. Interestingly, even the sub-stitution of Gln294 to Asn294, a modiﬁcation that is consid-
ered the most conservative one (since both residues are
uncharged derivatives of acidic residues, containing a terminal
carboxamide in place of a carboxylic acid), has led to an in-
crease in the speciﬁc RNase H activity. Therefore, it seems that
the only residue at position 294 that suppresses the RNase H
activity of HIV-2 RT is indeed the Gln found in the WT en-
zyme. Nonetheless, none of the 11 mutations incorporated at
position 294 of HIV-2 RT has any signiﬁcant eﬀect on the
noticeable level of the DNA polymerase activity of the enzyme.
These results strongly suggest that, despite its signiﬁcant eﬀect
on the RT-associated RNase H activity, Q294 appears to be
dispensable for the second RT-associated activity, the DNA
polymerase.
3.2. The strand-transfer activity of the mutant RTs
During the process of reverse transcription of the retroviral
RNA genome into double stranded DNA, there are two tem-
plate switches or strand-transfers [1]. Both the DNA polymer-
ase and RNase H functions of RT are simultaneously involved
in this course of action. The data presented here show (as
shown before for WT HIV-1 and HIV-2 RTs, chimeric HIV-
1/HIV-2 RT versions and the Q294P mutant of HIV-2 RT
[16,17]) that all new HIV-2 RT mutants possess similar
Fig. 2. The strand-transfer activity of the Gln294 HIV-2 RT mutants. (A) A schematic description of the strand-transfer assay of RT. The 32P end-
labeled 20nt synthetic DNA (thick line) was annealed to the 267 nt RNA transcript (thin line) that served as the primary RNA template. This hybrid
was mixed with 144 nt PG89 RNA transcript (dotted line), which serves as the acceptor RNA template. The lengths of the lines are not drawn to
scale. The four steps in the strand transfer process were described in detail previously [17]. (B and C) Each reaction consists of 0.1 lg heterodimeric
HIV-2 RT mutants that were incubated for 1 h at 37 C. Reaction products were analyzed by urea-PAGE followed by autoradiography. We show
here the autoradiograms of two gels of two independent experiments, conducted with the speciﬁed RT versions. The HIV-2 RT mutants were
designated as described in Fig. 1. The strong-stop 139 nt DNA transcript that is the product of the template primary RNA is marked by S and the
full-length 238 nt long transfer DNA product, generated after strand-transfer, is marked by T. The left lanes of each panel (marked as con) show the
products of the control reactions with HIV-1 RT in the absence of the secondary (acceptor) RNA transcript, generating only strong-stop 139 nt
products with no strand-transfer.
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minor diﬀerences observed reﬂect insigniﬁcant experimental
ﬂuctuations. This conﬁrms that Gln294 is involved primarilyin the RNase H RT function. With equal DNA polymerase
activities, diﬀerences in strand-transfer would be determined
for the most part by the diﬀerences in the RNase H activity.
Table 1
The relative enzymatic activities of the various Q294 HIV-2 RT mutants studied






WT HIV-1 (Pro) Non-polar 100 6.5 ± 0.7 5 ± 0.5
WT HIV-2 (Gln) Uncharged polar with amide group 100 1 1
Pro Non-polar 113 ± 10 5.1 ± 0.4 3.9 ± 0.5
Asn Uncharged polar with amide group 136 ± 13 4.9 ± 1.4 4.4 ± 0.1
Ser Uncharged polar with hydroxyl group 119 ± 2 6.9 ± 0.3 4.2 ± 0.8
Cys Thiol group 134 ± 9 9.2 ± 1 4.4 ± 0.5
Ala Small non-polar 112 ± 8 6.6 ± 0.2 2.9 ± 0.2
Glu Acidic 111 ± 3 4.0 ±0.2 4.1 ± 0.3
Arg Basic 135 ± 12 4.8 ± 0.6 3.4 ± 0.5
Q (p68)/R (p54) Basic (only in only p54) 106 ± 18 4.2 ± 0.3 3.7 ± 0.1
His Imidazole group 116 ± 1 4.2 ± 1.2 3.5 ± 0.4
Met Non-polar aliphatic with thiol-ether group 104 ± 5 4.3 ± 0.2 3.5 ± 0.6
Trp Aromatic with indole ring 113 ± 2 5.1 ± 0.5 4.5 ± 0.2
Tyr Aromatic with hydroxyl group 103 ± 4 4.8 ± 0.1 4.0 ± 0.1
The speciﬁc RNase H and resulting strand-transfer activities were calculated relative to the activity of wild-type (WT) HIV-2 RT and are expressed as
the factor by which the activity was increased. The initial RNase H activities were based on the quantitative evaluation of the reaction products,
generated after 15-second incubations, as detected by the PAGE analyses (shown in Fig. 1B). After background subtraction, the activity of every RT
version was calculated as follows: (A + B)/(A + B + C), where A, is the amount of 47 nt RNA products, B is the amount of the 38 nt products and C
is the amount of the uncleaved 267 nt RNA substrate. Then, the activity of each RT version was calculated relative to that of WT HIV-2 RT. Each
presented ﬁgure is the average (+/ range) of the data shown in Fig. 1B and those obtained from two other independent experiments (data not
shown). The strand-transfer activities were calculated from the generated full length 238 nt DNA product, as shown in Fig. 2B and C. After
background subtraction, the strand-transfer activity of every RT version was calculated as follows: (T)/(T + S), where T is the 238 nt strand-transfer
product and S is the strong stop 139 nt product (See Fig. 2B and C). Here again, the activity of each RT version was calculated relative to that of WT
HIV-2 RT, and each presented ﬁgure is the average (+/ range) of the data shown in Fig. 2B and C and two additional fully-independent experiments
(data not shown). In both RNase H and strand-transfer assays the autoradiography ﬁlms were scanned and the activity levels were calculated using
the densitometric software TINA (version 2.07d; Raytest Isotopenmessgeraete GmbH). The DNA polymerase activity of the all RT versions studied
was also calculated relative to wild-type HIV-2 RT and is expressed as percentages. In this assay, we have used 5 ng of each puriﬁed RT variant. All
values presented in the table are the averages (+/ range) of three independent experiments.
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activity of the mutants of HIV-2 RT on the levels of the RT-
associated strand-transfer function.
In the speciﬁc in vitro strand-transfer assay system em-
ployed, the synthesized full-length 238 nt DNA molecules rep-
resent the products of strand-transfer activity (see Fig. 2A).
The results indicate that the strand-transfer activity of all
HIV-2 RT Gln294 mutants tested was indeed higher than that
of the WT RT (Fig. 2B and C). These results were also quan-
tiﬁed, using three independently-performed experiments, and
the results are shown in Table 1, and as expected, there is a
good correlation between the strand-transfer activity and the
RNase H activity of all RT versions tested (Table 1).
3.3. Subunit-directed mutagenesis of HIV-2 RT Gln294
We have already shown that the involvement of Gln294 in
aﬀecting the RNase H activity of HIV-2 RT is primarily
through the p54 small RT subunit [16]. As we have shown in
the present study that all modiﬁcations performed in both
RT subunits have led to a substantial increase in the RNase
H activity, it was of interest to test whether the mutations af-
fect the activity when located in the small RT subunit. To this
aim, we have generated by subunit-directed mutagenesis an RT
version with the WT sequence in the p68 large subunit and the
Q294R mutation in the p54 smaller subunit (designated Q/R),
and the DNA polymerase, RNase H and strand-transfer func-
tions of the mutant were assayed (Figs. 1 and 2). As could be
expected, the data show that mutating just the p54 subunit was
enough to increase the speciﬁc RNase H activity by about
four-fold relative to the WT HIV-2 RT a factor that is quite
similar to the one obtained with the Q294R HIV-2 RT mutant,
in which both subunits carry the same mutation.4. Discussion
The results presented here further illuminate the critical role
of Gln294 in determining the level of the HIV-2 RT-associated
RNase H activity. Elucidation of the mechanism by which
Gln294 aﬀects the speciﬁc RNase H activity (and, conse-
quently, strand-transfer) requires structural insights. However,
no experimentally-derived structures of both HIV-1 and HIV-2
RTs with full-length substrate molecules (extending past the
RNase H active site towards the Gln294 position) exist. In
contrast, in the 1HYS structure [22] of HIV-1 RT, the bound
RNA–DNA hybrid appears to veer away from the position
of Pro294 (the HIV-1 RT homologous residue), which would
seem to preclude any involvement in the RNA degradation
mechanism. It has been proposed that HIV-RT can undergo
structural changes upon substrate binding and during the dif-
ferent stages of its reactions [23]. Indeed, superposition of the
apo-HIV-1 RT structure (1JKH) with the 1HYS structure
shows that the position of Pro294 moves about 5 A˚ closer to
the RNase H domain (data not shown). However, whether this
would bring either the substrate or the RNase H active site
into contact with the Gln294 cannot be determined. We can,
nonetheless, use structural insights, obtained from other crys-
tallographic studies of the RT, RNase H and other enzymes, to
model such possible interactions.
The human RNase H1 catalytic domain was recently crystal-
lized with diﬀerent lengths of the RNA–DNA heroduplex sub-
strate molecules [24]. These authors utilized this structure to
explore the function of the HIV-1 RT by superimposing the
human enzyme structure onto the RNase H domain of the
1HYS HIV-1 RT structure. Using conserved structural ele-
ments, it could be seen that six nucleotides straddle the active
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RNase H domain and the p51 thumb domain. Slight modiﬁca-
tions in the substrate are then required to avoid clashes. These
modiﬁcations force the RNA–DNA hybrid to pass directly
over the position of Pro294 (in HIV-1 RT), which is identical
to the position of the Gln294 residue in HIV-2 RT. In light of
this proposal, the presence of a polar residue (such as Gln) in-
stead of the Pro of HIV-1 RT could interact with the RNA
strand and, consequently, inhibit the progress of the enzyme.
The above argument does not, however, explain why a Gln
at position 294 would behave in a diﬀerent manner than all
other residues. If we look closely at the values in Table 1, we
can separate the diﬀerent residues into two subclasses. The
three smallest residues (Ala, Cys and Ser) have RNase H activ-
ities equal or better than that of HIV-1 RT. The second group
is broader with respect to their chemical identity and the eﬀects
on the RNase H activity. This group includes the slightly lar-
ger hydrophobic (Pro and Met), aromatic (Trp and Tyr) or po-
lar/charged (Glu, Arg, His and Asn) residues, which have all
RNase H activity levels that are reduced by between 20%
and 40% compared to that of WT HIV-1 RT. Both groups
of mutations have only a small reduction (60% and 90%) in
strand-transfer rates compared to HIV-1 RT. From analyzing
these mutated enzymes, we can conclude that the inhibitory ef-
fect of Gln (which has an 80% reduction in both RNase H
activity and strand-transfer activity when compared to HIV-
1 RT) must be due primarily to the combination of its lengthFig. 3. Molecular characteristics of p54 Gln294 in the structure of
HIV-2 reverse transcriptase. The crystal structure of HIV-2 RT (PDB
code 1MU2) was superimposed over the HIV-1 RT crystal structure
that includes the RNA–DNA hybrid (PDB code 1HYS). For clarity,
only, the two HIV-2 RT protein subunits (from 1MU2, p68 in green
and p54 in black) and the hybrid (from 1HYS, RNA in brown and
DNA in magenta) are depicted. The p54 Gln294 residue is shown in
orange spheres. RH, denotes the RNase H domain. The protein
molecules are overlaid with semi-transparent calculated electrostatic
potential (blue-positive, red-negative). The positively-charged cleft,
which may serve as the pathway by which the nucleic acids hybrid exits
the enzyme, is identiﬁed by the yellow arrow. A negatively-charged
patch seen behind Gln294 is positive in HIV-1 (see text for further
discussion).and polarity (but lack of charge) with its potential to form
hydrogen bonds with the substrate (see below).
However, there may be an additional complexity in the com-
parison between the two HIV RTs. Using the coordinates of
the HIV-2 RT crystal structure (1MU2), the electrostatic po-
tential of the surface of the RNase H domain and the p54
thumb domain was calculated using the PyMOL algorithm
[DeLano, W.L. The PyMOL Molecular Graphics System
(2002) on World Wide Web http://www.pymol.org]. The calcu-
lated potential is depicted in Fig. 3, overlaying the protein
structure. In order to identify the position of the bound
RNA–DNA hybrid, the 1HYS structure was superimposed
onto the 1MU2 structure (for clarity the 1HYS protein sub-
units are not shown). The p54 Gln294 residue (orange spheres)
is situated between a very positively charged cleft and a nega-
tively charged patch. A yellow arrow shows the probable direc-
tion of the RNA–DNA hybrid as it exits the RNase H active
site [24], and it is certainly feasible that this residue interacts
with the RNA–DNA hybrid. In HIV-1 RT, the protein surface
behind Pro294 is positive and not negative; suggesting that the
direction of the movement of this hybrid in the two related
RTs may be diﬀerent. While most reduction in RNase H activ-
ity of HIV-2 RT can be associated with the presence of Gln (as
opposed to the Pro residue in HIV-1 RT), the addition of a
change in the surface electrostatic potential in proximity to
Gln294 may also aﬀect the enzymes activity. It is also possible
that if a potentially-charged residue is introduced at the HIV-2
RT 294 site (Glu, Asp, Lys or Arg), the existence of the nega-
tive potential (behind) and positive potential (in front) may af-
fect the ability to form hydrogen bonds with the substrate.
Thus, for chemical and spatial reasons, it is likely that only
the relatively long and uncharged Gln can inhibit movement
of the substrate. A speciﬁc interaction between a Gln residues
and nucleic acids has been identiﬁed in the cases of a U1hpII
small RNA [25]. In addition, in the case of elongation factor
Tu [26], it was shown that a Gln can decrease the rate of poly-
merization of poly U, with respect to the same enzyme with a
smaller hydrophobic residue (Leu).
In light of the results presented here, it was of interest to
examine in all available published sequences of HIV-2 RT vari-
ants how conserved is Gln294 (Table 2 derived from http://
www.hiv.lanl.gov). All 21 sequenced isolates of HIV-2 RT
have a Gln294; hence, this unique residue is highly conserved.Table 2
The frequencies of the residues at position 294 in the RTs of various
variants of HIV-2, HIV-1 and SIVsmm
RT Q294 (%) No. of isolates
HIV-2 Q 100 21
SIVsmm Q 100 45











The presented ﬁgures were calculated from the data available at http://
www.hiv.lanl.gov.
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the fact that SIVsmm, which is the SIV strain mostly related to
HIV-2, harbors also Gln294 at all the sequenced isolates ana-
lyzed. This information strongly suggests that Gln294 is abso-
lutely required for the optimal viability of HIV-2 and SIVsmm.
This may also imply that the higher level of RNase H activity,
similar to that exhibited by HIV-1 RT, may be disadvanta-
geous in the context of the life cycle of HIV-2, and the lower
RNase H activity is suﬃcient for its proliferation. As to
HIV-1 RT, an inspection of 914 isolates of HIV-1 pol gene re-
veals that Pro294 is conserved in an overwhelming majority of
745 isolates (Table 2); thus, implying the importance of this
residue. However, in a relatively large number of isolates,
130, there is a Thr294 and 14 isolates possess a Ser294. Since
both Thr and Ser are uncharged polar residues with an OH
group, the relatively high incidence of both these mutations
(altogether 15.7%) is exceptional. Additionally, in 0.7% of
the HIV-1 isolates, there is an Ala294, in 0.4% an Ile, and in
lower incidences there are- Leu, Asn, Val, or a Glu at position
294. Interestingly, in 0.9% of HIV-1 RT variants there is a
Gln294. We have found that there is substantial reduction in
the RNase H activity of the recombinantly expressed P294Q
mutant of HIV-1 RT [16]. Therefore, it is likely that a combi-
nation of other RT mutations in these eight HIV-1 isolates
may compensate for the potentially-low RNase H activity of
these P294Q mutants of HIV-1 RT (by increasing the enzymes
activity). The relatively high incidence of the P294T and P294S
natural mutants should also indicate potentially interesting RT
properties. All in all, we plan to study soon these issues and re-
lated ones.
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